A Comparison of Classic and Virtual Inhaler Training Methods in COPD Patients
NCT ID: NCT05335265
Last Updated: 2022-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2021-10-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Additionally , patient's access to health services (especially face-to-face communication with recommended health providers) has been largely prevented due to the restrictions/requirements implemented against the pandemic in 2020,such as social isolation, staying away from public environments, and ensuring good personal and social hygiene.
Considering that inhaler training is done face-to-face by doctors or allied health personnel today, many patients did not receive inhaler drug use training. One of the most realistic solutions that we encountered with this pandemic is telemedicine. The use of internet-mediated training, which is a part of telemedicine, has come to the foreground. In a recently published study on chronic airway diseases (asthma and COPD), it was revealed that video-mediated inhaler training is as successful as classical face-to-face training (14).Our aim is to investigate whether video-mediated virtual inhaler training is successful in patients with COPD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nurse-led COPD Self-management Intervention
NCT04459546
The Effects of Telerehabilitation in Patients With COPD
NCT04879576
The Effect of Use of Breathing Exercise Device and Reading Aloud on Vital Signs
NCT04978831
The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients
NCT06733662
VIDEO-TRAINING-SESSION ON METERED DOSE INHALER SKILLS AMONG INDIVIDUALS WITH COPD
NCT04352829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
METHOD OF WORKING
Patients hospitalized due to COPD exacerbation and are ready to be discharged from the hospital will be included in this multicenter, prospective, randomized controlled study. Patients will be randomized according to a simple random numbers table, half of the patients will receive video-mediated virtual inhaler training (which is published on the Turkish Thoracic Society's official site and with permission for use obtained) and the other half will receive the same method as classical facial inhaler training videos.
Depending on the medical condition of the patients admitted to the ward, training will be implemented from the 24th hour of their hospitalization until their discharge stage, starting with 3 training sessions for 3 consecutive days. Upon hospital discharge, the technique of inhaler use evaluation will be carried out according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared using the Turkish Thoracic Society Patient's Booklet.
In inhaler technique training observation, inhaler technique control of the patient will be performed simultaneously by 2 observers independently (each observer will have a checklist) to demonstrate inter-observer consistency.
The patients will be called for a control appointment one week after hospital discharge, and their inhaler technique will be recorded once more using the "inhaler technique control form" by the same 2 observers independently.
RANDOMIZATION:
* ENVELOPE method will be used in randomization.
* Each clinic will prepare 12 envelopes, 6 of them will have a paper with the words VIRTUAL EDUCATION and 6 of them CLASSIC EDUCATION. The patient will be asked to draw one of these mixed envelopes. The form of education in the envelope will be applied to the patient.
Protocol:
* Before discharge, the patient should receive a Metered-Dose Inhaler (MDI) training for 3 consecutive days.
* Classical education (face-to-face education):
* The person who will provide this training must be a health worker who is an expert in their field.
* The health personnel who will provide the training should watch the Turkish Thoracic Society MDI training video before giving the training and convey the steps there to the patient (to ensure the patients receive training on an equal basis with the patient who will receive video training).
* Training should be given 3 times on the first day, 2 times on the 2nd day, and once on the 3rd day.
* During discharge, inhaler technical evaluation should be done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society.
* The people who will evaluate the patient's inhaler technique on the day of discharge should be someone different from the health personnel who provided the training.
* In inhaler technique observation, the patient's inhaler technique control should be performed simultaneously by 2 observers independently (each observer will have a checklist) to demonstrate inter-observer consistency.
Virtual training (video training):
* On the first day's training, the video should be watched 3 times a day, on the 2nd day the video should be watched 2 times during the day, on the 3rd day (discharge) the video should be watched once.
* In video training, the Turkish Thoracic Society Virtual Training Video, (a copy of the video has been provided ), will be used.
* During discharge, inhaler technical evaluation should be done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society.
* The people who will evaluate the patient's inhaler technique on the day of discharge should be someone different from the health personnel who provided the training.
* In inhaler technique observation, the patient's inhaler technique control should be performed simultaneously by 2 observers independently (each observer will have a checklist) to demonstrate inter-observer consistency.
* Upon hospital discharge, the patient should be prescribed a short-acting bronchodilator MDI (This is already recommended for all patients in Groups A, B, C, and D according to the GOLD guidelines. In this respect, our study does not fall under a drug study).
* They should not be advised to watch or not watch the Inhaler Training Video at home (If we allow them to access and watch the video at home, it will create bias). The decision of whether to watch the video at home should be left to the patient (a question will be asked about this at the control. It has been added to the form).
* The first control after discharge should be done in the 1st week. Patients who cannot come to the hospital for a control appointment due to the pandemic will be called by phone and inhaler techniques will be checked with video conversation. (There is no legal issues as no image recording will be taken here).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
"Envelope" method was used in randomization.
-Each clinic prepared 12 envelopes, 6 of them have a paper with the words VIRTUAL EDUCATION and 6 of them CLASSIC EDUCATION. The patient was asked to draw one of these mixed envelopes. The form of education in the envelope was applied to the patient.
SUPPORTIVE_CARE
NONE
-Each clinic prepared 12 envelopes, 6 of them have a paper with the words VIRTUAL EDUCATION and 6 of them CLASSIC EDUCATION. The patient was asked to draw one of these mixed envelopes. The form of education in the envelope was applied to the patient.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FIT (face-to-face inhaler training)
Face-to-face inhaler training.
o The trainers watched the Turkish Thoracic Society (TTS) MDI training video before giving the training.
Training given 3 times on the first day, 2 times on the 2nd day, and once on the 3rd day.
During discharge, inhaler technic was checked according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by TTS.
The trainer and the inhaler technical controller are different.
Treatment training
Face-to-face:Metered-DoseInhalerTraining gave 3 times on the 1st day, 2 times on the 2nd day, once on the 3rd day.During discharge, inhaler technical evaluation were done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society (TTS).The people who is evaluate the patient's inhaler technique (IT) on the day of discharge was someone different from the health personnel who provided the training. In IT control, the patient's performance was evaluated simultaneously by 2 observers.
Video training:Training gave 3 times on the 1st day, 2 times on the 2nd day,once on the 3rd day.The TTS-Virtual Training Video were used.During discharge,inhaler technical evaluation was done same with face-to-face training.The person who is evaluate the patient's IT was someone different from the training personnel.In IT observation,it was used same method with face-to-face training.
VIT (virtual inhaler training)
Virtual Training was gave 3 times on the first day, 2 times on the 2nd day, and once on the 3rd day (discharge) by the TTS Virtual training video.
During discharge, inhaler technics of the patient's were controlled according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by the TTS.
o The inhaler technique controller and the trainer are different.
Treatment training
Face-to-face:Metered-DoseInhalerTraining gave 3 times on the 1st day, 2 times on the 2nd day, once on the 3rd day.During discharge, inhaler technical evaluation were done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society (TTS).The people who is evaluate the patient's inhaler technique (IT) on the day of discharge was someone different from the health personnel who provided the training. In IT control, the patient's performance was evaluated simultaneously by 2 observers.
Video training:Training gave 3 times on the 1st day, 2 times on the 2nd day,once on the 3rd day.The TTS-Virtual Training Video were used.During discharge,inhaler technical evaluation was done same with face-to-face training.The person who is evaluate the patient's IT was someone different from the training personnel.In IT observation,it was used same method with face-to-face training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment training
Face-to-face:Metered-DoseInhalerTraining gave 3 times on the 1st day, 2 times on the 2nd day, once on the 3rd day.During discharge, inhaler technical evaluation were done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society (TTS).The people who is evaluate the patient's inhaler technique (IT) on the day of discharge was someone different from the health personnel who provided the training. In IT control, the patient's performance was evaluated simultaneously by 2 observers.
Video training:Training gave 3 times on the 1st day, 2 times on the 2nd day,once on the 3rd day.The TTS-Virtual Training Video were used.During discharge,inhaler technical evaluation was done same with face-to-face training.The person who is evaluate the patient's IT was someone different from the training personnel.In IT observation,it was used same method with face-to-face training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having COPD diagnosed with PFT (FEV1/FVC \<70 in PFT in the last 1 year)
* Being hospitalized with a COPD exacerbation and being discharged
* Not having a hearing loss, mental disability, visual impairment and a physical impairment that would prevent the use of MDI
* To have the necessary technological equipment to establish video communication on the phone
* Who have agreed to participate in the study.
Exclusion Criteria
* Having a hearing loss, mental disability, visual impairment and a physical impairment that would prevent the use of MDI
* Have not the necessary technological equipment to establish video communication on the phone
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ayse Baha
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayse Baha
Associate Professor, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ayse Baha
Role: STUDY_CHAIR
Near East University Faculty of Medicine
Dilek Yapar
Role: PRINCIPAL_INVESTIGATOR
Antalya Muratpasa District Health Directorate
Aylin O Alpaydin
Role: PRINCIPAL_INVESTIGATOR
Dokuz Eylül University Faculty of Medicine
Aycan Yuksel
Role: PRINCIPAL_INVESTIGATOR
Ufuk University
Ayshan Mammadova
Role: PRINCIPAL_INVESTIGATOR
Gazi University Faculty of Medicine
Ali Uzan
Role: PRINCIPAL_INVESTIGATOR
Near East University Faculty of Medicine
Deniz Kizilirmak
Role: PRINCIPAL_INVESTIGATOR
Celal Bayar University Faculty of Medicine
Esen S Gulensoy
Role: PRINCIPAL_INVESTIGATOR
Ufuk University
İlknur Kaya
Role: PRINCIPAL_INVESTIGATOR
Kütahya Faculty of Health Science
Irem Serifoglu
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Bilkent
Ismail Zehir
Role: PRINCIPAL_INVESTIGATOR
Kütahya Faculty of Science
Merve Y Senel
Role: PRINCIPAL_INVESTIGATOR
Balıkesir State Hospital
Nalan Ogan
Role: PRINCIPAL_INVESTIGATOR
Ufuk University
Nurdan Kokturk
Role: PRINCIPAL_INVESTIGATOR
Gazi University Faculty of Medicine
Secil Sari
Role: PRINCIPAL_INVESTIGATOR
Celal Bayar University Faculty of Medicine
Umran O Sertcelik
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospiatl
Zuleyha Galata
Role: PRINCIPAL_INVESTIGATOR
Gazi University Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara City Hospital
Ankara, , Turkey (Türkiye)
Gazi University Faculty of Medicine
Ankara, , Turkey (Türkiye)
Ufuk University Faculty of Medicine
Ankara, , Turkey (Türkiye)
Muratpasa District Health Directorate
Antalya, , Turkey (Türkiye)
Balıkesir State Hospital
Balıkesir, , Turkey (Türkiye)
Dokuz Eylul University, Faculty of Medicine
Izmir, , Turkey (Türkiye)
Kütahya University of Health Sciences
Kütahya, , Turkey (Türkiye)
Celal Bayar University Faculty of Medicine
Manisa, , Turkey (Türkiye)
Near East University Faculty of Medicine
Mersin-10, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YDU/2021/89-1302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.